Company Number: 14935602

Analysis Date: 2025-07-29 20:20 UTC

Financial Health Assessment for NATURAL BIOTECH LIMITED

---

1. Financial Health Score: Grade D

Explanation:
Given the company is newly incorporated (June 2023), classified as dormant, and reports minimal financial activity and assets, it is in the very early stages of its financial life cycle. The extremely limited financial data and low asset base restrict a robust health score. Grade D reflects a startup entity with no active trading or financial performance to date, indicating "nascent" financial health with many unknowns ahead.

---

2. Key Vital Signs

Metric	Value	Interpretation
Incorporation Date	2023-06-14	Very recent startup, early phase of business lifecycle.
Status	Active	Company is legally operational and compliant.
Account Category	Dormant	No significant financial transactions in reporting period.
Cash at Bank	£1	Practically no operating cash flow or liquidity.
Net Assets	£2	Minimal net worth, solely share capital and cash.
Shareholders Funds	£2	Equity reflects nominal shares issued, no retained earnings.
Directors	2 (both active)	Leadership in place; experienced commercial and managing directors.
PSC Control	Two individuals each with 25-50% shares and voting rights	Concentrated ownership and control, typical for a startup.
SIC Code	20200	Manufacture of pesticides and agrochemical products – capital intensive and regulated.

---

3. Diagnosis: What the Financial Data Reveals

The company is currently in a dormant state, meaning it has not yet commenced active trading or significant business operations. The financial "vital signs" show a "flatline" scenario with no revenue, expenses, or operational cash flows recorded. The balance sheet is minimal, showing only nominal share capital and a token cash balance, which is insufficient for any business activity.

This "dormant" condition is common for newly formed companies preparing to start trading or awaiting regulatory approvals, especially in specialized manufacturing industries such as agrochemicals. The absence of liabilities and expenses suggests no financial distress or obligations at this stage.

The two directors, acting as commercial and managing directors, indicate that governance structures are in place, which is positive. The concentrated ownership structure means that decision-making is streamlined but also dependent on these individuals' strategic direction.

---

4. Recommendations: Steps to Improve Financial Wellness

1. Activate Operations:
   Transition from dormant to active status by commencing business activities and generating revenue streams. This is critical to move from a "financial coma" to a "healthy pulse" of operational cash flow.

2. Capital Injection and Cash Management:
   Increase working capital beyond nominal levels to fund initial operational costs, R&D, regulatory compliance, and marketing efforts. Healthy cash reserves are essential to avoid liquidity distress.

3. Financial Planning and Forecasting:
   Develop detailed budgets, cash flow forecasts, and break-even analysis tailored for the agrochemical manufacturing sector. This proactive approach identifies potential financial "symptoms" early (e.g., cash shortages).

4. Regulatory Compliance Preparation:
   Given the industry, ensure all licenses, environmental, and safety approvals are in place before full-scale operations. Financial contingencies should be planned for regulatory costs.

5. Regular Financial Monitoring:
   Implement monthly or quarterly financial reporting to track liquidity, asset utilization, and emerging liabilities. Early detection of financial "symptoms" like overspending or delayed receivables will help in timely interventions.

6. Seek Expert Advice:
   Engage with financial advisors or accountants experienced in startups and regulated manufacturing to guide capital structure, taxation, and compliance frameworks.

---